LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

ABBV

185.08

+1.61%↑

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

ABBV

185.08

+1.61%↑

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

ABBV

185.08

+1.61%↑

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

ABBV

185.08

+1.61%↑

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

ABBV

185.08

+1.61%↑

Home・Stock List・Merck & Co Inc.

Merck & Co Inc.

Closed

Sector Healthcare

125.13 -0.6

Buy Sell

Overview

Share price change

24h

Current

Min

125.03

Max

128.65

Key metrics
By Trading Economics
Income	6B 4.8B
Sales	1.2B 16B
P/E Sector Avg	942.5 79.786
EPS	2.07
Profit margin	30.139
Employees	72,000
EBITDA	-557M 7B

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+16.81 upside

Dividends
By Dow Jones
Next Earnings	30 Jul 2024
Next Dividend date	7 Oct 2024
Next Ex Dividend date	16 Sept 2024

Market Stats
By TradingEconomics
Market Cap	2B 324B
Previous open	125.73
Previous close	125.13

News Sentiment

By Acuity

35%

65%

77 / 369 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

124.56 / 125.89 Support & Resistance

Merck & Co Inc. Chart

Related News

30 May 2024, 19:36 UTC

Major Market Movers

Summit Therapeutics Shares Triple After Drug Candidate Data

29 May 2024, 14:38 UTC

Acquisitions, Mergers, Takeovers

Trending: Merck to Buy Biotech Company EyeBio for $1.3 Billion

29 May 2024, 11:13 UTC

Acquisitions, Mergers, Takeovers

Merck to Acquire EyeBio for $1.3 Billion

12 Jul 2024, 10:45 UTC

Acquisitions, Mergers, Takeovers

Merck to Post 3Q Charge of About $1.3 Billion, or 50c/Share, on EyeBio Deal >MRK

12 Jul 2024, 10:45 UTC

Acquisitions, Mergers, Takeovers

Merck Completes Acquisition Of EyeBio >MRK

9 Jul 2024, 12:30 UTC

Acquisitions, Mergers, Takeovers

Merck Animal Health Completes Acquisition Of Elanco's Aqua Business >MRK

9 Jul 2024, 12:29 UTC

Acquisitions, Mergers, Takeovers

Elanco Animal Health Sees Ending 2024 With Net Debt to Adjusted Ebitda in Mid-4x Range >ELAN

9 Jul 2024, 12:28 UTC

Acquisitions, Mergers, Takeovers

Elanco Animal Health: $1.05B-$1.1B Net Proceeds Available for Debt Paydown in 3Q >ELAN

9 Jul 2024, 12:28 UTC

Acquisitions, Mergers, Takeovers

Elanco Completes Sale of Aqua Business to Merck >ELAN MRK

25 Jun 2024, 08:52 UTC

Hot Stocks

Stocks to Watch Tuesday: Nvidia, Airbus, FedEx -- WSJ

29 May 2024, 15:56 UTC

Earnings

Acquisitions, Mergers, Takeovers

The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why. -- Barrons.com

29 May 2024, 15:28 UTC

Earnings

Hot Stocks

Stocks to Watch Wednesday: Marathon Oil, American Airlines, Chewy, Robinhood -- WSJ

29 May 2024, 14:23 UTC

Acquisitions, Mergers, Takeovers

Trending: Merck to Buy Biotech Company EyeBio for $1.3B

29 May 2024, 11:04 UTC

Acquisitions, Mergers, Takeovers

Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio -- Update

29 May 2024, 10:58 UTC

Acquisitions, Mergers, Takeovers

Merck to Acquire EyeBio for $1.3B

29 May 2024, 10:55 UTC

Acquisitions, Mergers, Takeovers

Merck To Buy EyeBio In A Deal That Could Valued At Up To $3 Billion -- MarketWatch

29 May 2024, 10:45 UTC

Acquisitions, Mergers, Takeovers

Merck To Acquire EyeBio for a $1.3B Upfront Payment and Up to $1.7B in Future Milestone Payments for a Potential Value of $3B >MRK

29 May 2024, 10:45 UTC

Acquisitions, Mergers, Takeovers

Merck To Acquire EyeBio >MRK

29 May 2024, 08:58 UTC

Earnings

Hot Stocks

Stocks to Watch Wednesday: American Airlines, Robinhood, Marathon Oil -- WSJ

29 May 2024, 01:04 UTC

Peer Comparison

Price change

Merck & Co Inc. Forecast

Price Target

By TipRanks

16.81% upside

12 Months Forecast

Average 147 USD 16.81%

High 168 USD

Low 134 USD

Based on 16 Wall Street analysts offering 12 month price targets forMerck & Co Inc. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

16 ratings

Buy

Hold

Sell

Based on 16 analysts giving stock ratings to Merck & Co Inc. - Dist in the past 3 months.

Technical Score

By Trading Central

124.56 / 125.89Support & Resistance

All events are bearish.

The bullish and bearish events are balanced.

All events are bullish.

Sentiment

By Acuity

77 / 369 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Merck & Co Inc.

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.